CAPZA exits Winback, after backing the Group since 2021

Charterhouse Capital Partners today announces that it has agreed to invest in Winback, a leading French medtech company specialising in non-invasive medical, rehabilitation, sports recovery, and aesthetic technologies, in partnership with Winback’s management team, who will reinvest significantly in the business. CAPZA, the existing minority shareholder, which has backed the group since 2021, will exit as part of the transaction.

Founded in 2013, Winback is a global leader specialising in TECAR and radiofrequency therapy, cryotherapy and compression systems and digital service solutions used across physiotherapy, sports medicine, chronic pain, women’s health, and aesthetic care. Headquartered in Biarritz, France, the platform has a fully integrated value chain including proprietary technology that services over 15,000 clinics and practices across 55 countries, with circa 60% of its sales generated internationally.

Winback benefits from favourable industry tailwinds across the global health and wellness market, including increasing demand for non-drug solutions, strong growth in post-surgery rehabilitation and a rising focus on prevention, rapid recovery and performance.

Charterhouse will use its proven expertise in building and internationalising leading European companies across the healthcare space to support the next stage of Winback’s growth journey, in partnership with the company’s management team.

Today’s announcement follows other recent healthcare investments by Charterhouse, one of its two sectors of specialisation, including Metrodora, a Spanish provider of training and education for healthcare professionals, and Skin Tech Pharma Group, a leading B2B medical aesthetics platform.

It also recently welcomed new investors in Novétude Group, which Charterhouse first invested in in 2020, as it continues to help the company grow into a leading pan-European healthcare education platform.
 

Fabien Bernez, Partner at CAPZA, said: “During our partnership with Winback, the company has significantly strengthened its international footprint and expanded across physiotherapy, sports and aesthetic applications. We are pleased to have supported two outstanding entrepreneurs and their team during this phase of growth. We are now delighted to hand over the reins to Charterhouse and are confident that they are the right partner to guide the business through its next stage of global expansion.”

Pierre de Sarrau and Cédric Barthélemy, both Partners at Charterhouse, said: “Winback represents the very best of European medtech innovation: proprietary technology, strong clinical credibility, and deep expertise across physiotherapy, sports recovery and aesthetic care. Our investment builds on Charterhouse’s long-standing track record in healthcare and we are excited to partner with Winback’s leadership team to accelerate the company’s international expansion and reinforce its position as a global leader in non-invasive treatment solutions.”

Christophe Buée and Pierre Lebas, Co-CEOs of Winback, said: “Partnering with Charterhouse, a firm with deep healthcare expertise and a clear vision for international growth, marks an important milestone in our growth journey. Together, Winback is well positioned to continue to expand globally, accelerate innovation and enhance the experience we offer to healthcare professionals and patients worldwide. We would also like to thank the CAPZA team for their support during our four-year journey.”

 
 
This document is aimed solely at the media and is for information purposes only. The opinions expressed here are the views of the author and do not constitute investment advice. This is not a recommendation to purchase, sell or subscribe to financial instruments, an offer to sell investment funds or an offer of financial services. This press release is as dated. They do not necessarily represent the views of any company within the AXA Investment Managers Group and may be subject to change without notice. This does not constitute a Financial Promotion. This is for information purposes only. No financial decisions should be made on the basis of the information provided. Past performance is not necessarily representative of future results: performance is not constant over time and the value of investments may fall as well as rise.
 
Information about the staff team Flex Equity of CAPZA is only informative. We do not guarantee the fact that staff remain employed by CAPZA and exercise or continue to exercise in the Flex Equity team of CAPZA.